Brief Summary
Type:
Leukemias
Study Type:
Treatment
Phase:
I
ClinicalTrials.gov Identifier:
NCT02303821
Study #:
CMH - Amgen2014
Start Date:
Aug 16, 2020
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT02303821
View Complete Trial Details & Eligibility at ClinicalTrials.gov
